Covestor’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Covestor’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20	Closed	–	–	2889
2024 Q1	$0	Buy	20 +13	+186%	+$200	﹤0.01%	2880
2023 Q4	$0	Sell	7 -3	-30%	-$38	﹤0.01%	2854
2023 Q3	$0	Buy	10 +3	+43%	+$41	﹤0.01%	2853
2023 Q2	$0	Hold	7	–	–	﹤0.01%	2791
2023 Q1	$0	Hold	7	–	–	﹤0.01%	2723
2022 Q4	$0	Buy	+7	New	+$114	﹤0.01%	2746
2022 Q1	–	Sell	-14	Closed	–	–	2512
2021 Q4	$0	Buy	+14	New	+$263	﹤0.01%	2339

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Covestor's DCPH Position: Q2 2024 in Review

Covestor sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 20 shares.

Covestor first reported a position in DCPH in Q4 2021 and held it in 7 quarters. The position peaked at $0 in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Covestor reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Covestor sold 20 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024.
Covestor first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Covestor's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Covestor's 13F filing for Q2 2024, filed 9 Aug 2024.